<DOC>
	<DOCNO>NCT00814359</DOCNO>
	<brief_summary>Radiation treatment effective treating cancer head neck , however , course treatment , common patient experience soreness mouth throat due radiation . When radiation cause inflammation inside mouth , call 'mucositis ' . There several mouthwash commonly use prevent treat mucositis , none show superior another . This study conduct see use combination magic mouthwash sucralfate well use single mouthwash call benzydamine decrease burden mucositis .</brief_summary>
	<brief_title>Magic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride Treatment Radiation-induced Mucositis</brief_title>
	<detailed_description>Sixty patient head neck cancer treat 6 week radiotherapy , randomly assign receive either combination magic mouthwash ( diphenhydramine , dexamethasone nystatin ) plus sucralfate benzydamine . Patients randomize receive magic mouthwash plus sucralfate rinse first 5ml magic mouthwash 2 minute swallow , follow rinse 5ml 1g/5ml sucralfate 2 minute swallow , 4 time daily . Patients randomize receive 0.15 % benzydamine HCl instruct rinse 15ml solution 2 minute expectorate , 4 time daily . Patients start mouthwash regimen prior initiation radiotherapy , stop 2 week completion radiotherapy .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Benzydamine</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Sucralfate</mesh_term>
	<criteria>Histologically proven squamous cell carcinoma head neck . Receiving 6 week external beam radiotherapy treatment volume include mucosal surface head neck . Age le 18 year ECOG Performance Score 2 high Patient unable understand protocol and/or unable provide inform consent Patient unable unwilling complete questionnaire write English . Prior radiation head neck region would result overlap field current study . Plan receive radiation treatment volume include larynx hypopharynx plan treatment locoregional lymph node . Plan receive concurrent chemotherapy agent cisplatin . Plan receive investigational agent ( eg . panitumumab ) . Investigational agent kind within 30 day prior randomization . Concurrent administration experimental intervention give purpose prevent oral mucositis . History allergic hypersensitivity reaction possible agent administer study . Patients pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>mucositis</keyword>
	<keyword>radiation</keyword>
	<keyword>magic mouthwash</keyword>
	<keyword>sucralfate</keyword>
	<keyword>benzydamine</keyword>
	<keyword>diphenhydramine</keyword>
	<keyword>dexamethasone</keyword>
	<keyword>nystatin</keyword>
</DOC>